[1]柏书博综述,王敬晗,陈贵敏审校.抑癌基因LKB1与肿瘤关系的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2016,18(04):408-410,414.[doi:10.3969/j.issn.1672-271X.2016.04.022]

点击复制

抑癌基因LKB1与肿瘤关系的研究进展()

分享到62.8K

参考文献/References:

[1]Green AS, Chapuis N, Lacombe C, et al. LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology[J]. Cell Cycle, 2011,10 (13):2115-2120.
[2]Feng Y, Wang Y, Wang Z, et al. The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss[J]. Cancer Res, 2012,72(24):6502-6511. [3]Osoegawa A, Kometani T, Nosaki K, et al．LKBl mutations frequently detected in mucinous bronchioloalveolar carcinoma[J]．Jpn J Clin Oncol, 2011, 41(9):1132-1137.
[4]Van Veelen W, Korsse SE, van de Laar L, et al. The long and winding road to rational treatment of cancer associated with LKB1，AMPK/TSC/mTORCl signaling[J]．Oncogene, 2011, 30(20):2289-2303.
[5]Mehellou Y, Alessi DR, Macartney TJ, et al.Structural insights into the activation of MST3 by MO25[J]. Biochem Biophys Res Commun, 2013,431(3): 604-609.
[6]EkmanS，Wynes MW，Hirsch FR. The mTOR pathway in lung cancer and implications for therapy and biomarker analysis[J]. Thorac Oncol, 2012,7(6)：947-953.
[7]Grewe M, Gansauge F, Schmid RM, et al. Regulation of cell growth and cyclin D1 expression by the constitutively active FPAP-p70s6K pathway in human pancreatic cancer cells [J].Cancer Res, 1999,59(15):3581-8587.
[8]Nanjundan M, Byers LA, Carey MS, et al. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence[J]. Thorac Oncol, 2010, 5(12):1894-1904．
[9]Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint[J]. Mol Cell, 2008, 30(2):214-226.
[10]Tanwar PS, Kaneko arui T, Zhang L, et al. Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis[J]. Hum Mol Genet, 2012, 21(20):4394-4405.
[11]Chan CH, Jo U. Posttranslational regulation of Akt in human cancer[J]．Cell Biosci, 2014,4(1):59-67.
[12]Boudeau J, Sapkota G, Alessi DR. LKBl, a protein kinase regulating cell proliferation and polarity[J]. FEBS Lett, 2003, 546(1):159-165．
[13]Jimenez AI, Fernandez P, Dominguez O, et al. Growth and molecular profile of lung cancer cells expressing ectopic LKBl：down-regulation of the phosphatidylinositol 3"- phosphate kinase/PTEN pathway[J]. Cancer Res, 2003, 63(6):1382-1388．
[14]Shorning BY, Griffiths D, Clarke AR. Lkb1 and Ptensynergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder[J]. PLoS One, 2011, 6(1):e16209.
[15]Gill RK, Yang SH, Meerzaman D, et al．Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer[J]．Oncogene, 2011, 30(35):3784-3791.
[16]田胜国, 董景珍, 于锦萍，等. LKB1和VEGFR在不同分期非小细胞肺癌中的表达[J].临床肺科杂志，2014,19(10): 1883-1884.
[17]王国臣,李作生,侯静朴,等. LKB1和VEGFR2评价肺腺癌预后的意义[J]. 临床肺科杂志,2013,18(6):1096-1097.
[18]池菲, 张新, 才虹美，等. LKB1在非小细胞肺癌细胞的表达及其与Survinin相关性的研究[J].临床和实验医学杂志,2016,15(10):972-975.
[19]Liang X，Li ZL，Jiang LL，et al．Suppression of lung cancer cell invasion by Lkb1 is due to the downregulation of tissue factor and vascular endothelial growth factor， partly dependent on SP1[J]．Int J Oncol, 2014, 44(6):1989-1997.
[20]梁璇,南克俊, 徐勤技，等. 丝氨酸/苏氨酸蛋白激酶1基因沉默对肺癌细胞生物学行为的影响[J].南方医科大学学报，2007，27(9): 1303-1306.
[21]Safe S, Abdelrahim M．Sp transcription factor family and its role in cancer[J]．Eur J Cancer, 2005,41(16):2438-2448.
[22]李利义，罗越，周玲玲，等. 胃癌组织中LKBl和VEGF-C的表达及其意义[J]. 医学研究杂志，2015，44(9):81-84.
[23]徐新宇，夏雷莫，莫伏根，等.肝激酶B1和p53在胃癌组织中的表达及其临床意义[J].肿瘤研究与临床，2014,26(7):451-453.
[24]孙俊杰. 肝激酶B1（LKB1）mRNA 表达与胃癌预后的相关性研究[J].世界最新医学信息文摘，2014,14(35):11-14.
[25]沈赞, 吴晴，岳麓，等. 抑癌基因LKB1在乳腺癌组织中的表达及其临床意义[J].中华医学杂志，2005,85(1):15-18.
[26]庄志刚，蒋蓓琦，李正东，等. LKBl基因沉默对乳腺癌细胞生物学行为的影响[J].同济大学学报(医学版), 2010,31(6):11-12.
[27]庄志刚, 狄根红,侯意，等. LKBl基因与乳腺癌细胞侵袭性相关因子的研究[J]. 中华医学杂志，2007,87(2):81-84.
[28]庄志刚，贺其志，蒋蓓琦，等.LKBl基因在不同基因亚型乳腺癌中表达的意义[J].现代肿瘤医学，2010,18(12):2363-2366.
[29]张志强, 王梓瑛, 王晓舟，等.LKB1 对胰腺癌细胞迁移侵袭及上皮间质转化的影响及机制研究[J].实用癌症杂志，2016,31(3):362-365. [30]Gu Y, Lin S, Li JL, et al. Altered LKB1/CREB-regulated transcription co-activator(CRTC)signaling axis promotes esophageal cancer cell migration and invasion[J]. Oncogene,2012,31(4):469-479． [31]黄约翰，何彬，李鹏，等.LKB1在肝细胞癌中的表达及其对预后的影响[J].肝胆胰外科杂志，2013,25(6):467-470.

相似文献/References: